Yellow fever is a mosquito-borne viral infection that can range from a mild, flu-like illness to a life-threatening attack on the liver and kidneys. Spread by infected mosquitoes in parts of Africa and South America, the yellow fever virus takes its name from the jaundice, or yellowing of the skin and eyes, that appears in its most severe form. Many people who catch it feel only briefly unwell, but a smaller group goes on to develop a dangerous toxic phase with bleeding and organ failure. The reassuring part of the story is that a single dose of a highly effective vaccine can protect you for life. This guide explains what yellow fever is, how to recognize its symptoms, how it spreads, how doctors diagnose it with blood tests, and what current treatment, prevention, and research have to offer.
What is yellow fever?
Yellow fever is caused by a flavivirus, part of the same viral family that includes dengue, Zika, and West Nile virus. It has circulated for centuries in tropical regions and once caused devastating urban epidemics, including in port cities of the Americas and Europe, before its mosquito origin was understood. Today the virus is endemic in 27 countries across sub-Saharan Africa and 13 countries in tropical South America, where it continues to cause outbreaks despite the availability of a vaccine.
Because it belongs to this family, yellow fever shares early symptoms with several other tropical infections, and returning travelers with a fever are often evaluated alongside the dengue fever symptoms, causes, and treatment guide. The overlap can be close enough that clinicians also consider the Zika virus symptoms, causes, and treatment guide when someone develops fever and aches after visiting an affected area. What sets yellow fever apart is its ability, in a minority of cases, to damage the liver and trigger severe bleeding.
Symptoms of yellow fever
Many yellow fever infections are mild or produce no symptoms at all. When illness does appear, it usually begins 3 to 6 days after an infected mosquito bite and starts abruptly. This first, or acute, phase brings fever and a cluster of aches that can be intense but typically eases within three to four days, and most people recover completely at this point.
The concern is that roughly 1 in 7 people who develop symptoms enter a second, far more dangerous toxic phase within a day or so of seeming to improve. In this phase the fever returns, the liver and kidneys begin to fail, and bleeding can appear from the mouth, nose, eyes, or stomach. The table below summarizes the symptoms across both stages.
| Symptom | What it usually feels like |
|---|---|
| Fever and chills | A sudden high temperature at the start of the acute phase, often with shivering |
| Severe headache and body aches | Strong pain in the head, back, and muscles that can be hard to ignore |
| Nausea and vomiting | An upset stomach with loss of appetite and, sometimes, vomiting |
| Jaundice | Yellowing of the skin and the whites of the eyes, a warning sign of the toxic phase |
| Dark urine and abdominal pain | Tea-colored urine and belly pain that suggest the liver is under strain |
| Bleeding | Bleeding from the gums, nose, eyes, or digestive tract in severe disease |
How yellow fever spreads: causes and risk factors
Yellow fever spreads through the bite of an infected mosquito, and it cannot pass directly from one person to another through everyday contact. The virus moves in a cycle between mosquitoes and hosts, and scientists describe three overlapping transmission patterns. In the jungle, or sylvatic, cycle, forest mosquitoes such as Haemagogus and Sabethes species carry the virus between monkeys, and people who work or travel in the forest can be bitten. In the urban cycle, the Aedes aegypti mosquito spreads the virus from person to person in towns and cities, which is how large epidemics take off. An intermediate savannah cycle also occurs in the moist grasslands of Africa.
Your risk depends largely on where you go and whether you are protected. Unvaccinated travelers to endemic parts of Africa and South America face the highest exposure, along with people who live in or near forested areas. Because these same regions carry other insect-borne diseases, travelers frequently compare the mosquito-borne risks explained in this malaria guide when planning a trip and deciding which precautions they need.
The yellow fever vaccine and the “yellow card”
The single most important fact about yellow fever is that a safe, effective vaccine exists. The vaccine uses a weakened live strain of the virus known as 17D, and a single dose prompts the immune system to build lasting protection. Immunity develops in about 80 to 100 percent of people within 10 days and in more than 99 percent within a month. The World Health Organization now considers one dose enough to protect a person for life, and a booster is no longer recommended for most people.
Because the disease can cross borders, many countries require proof of vaccination before you enter or after you travel through an endemic area. That proof is recorded on an International Certificate of Vaccination or Prophylaxis, widely known as the yellow card, which has been valid for the lifetime of the vaccinated person since 2016. The vaccine is given at designated vaccination centers, ideally at least 10 days before travel. It is a live vaccine, so it is generally avoided in infants under 6 to 9 months, during pregnancy, and in people with weakened immune systems or severe egg allergy, and older first-time recipients are counseled about rare but serious reactions. A clinician can help you weigh these factors before a trip.
How yellow fever is diagnosed
Because early yellow fever looks like many other tropical fevers, doctors rely on your travel history together with laboratory testing to confirm it. The best test depends on how long you have been ill. In the first few days after symptoms begin, a molecular test called RT-PCR can detect the virus’s genetic material in the blood. Later, once the virus itself is clearing, laboratories look instead for antibodies the immune system has made against it, usually the IgM type that signals a recent infection. Because flaviviruses cross-react on antibody tests, a positive result may need a confirmatory neutralization test to separate yellow fever from dengue, Zika, or a past vaccination.
Blood work also tells doctors how hard the virus is hitting the organs, and this is where routine lab markers become valuable. As the virus injures liver cells, it spills enzymes into the bloodstream, so laboratories measure the enzyme described in the AST lab test guide and the companion enzyme covered in the ALT liver test guide, both of which can climb sharply in severe disease. As the liver falters, waste pigment builds up, which is why clinicians track the pigment measured in the total bilirubin blood test guide to gauge jaundice. Bleeding risk rises as clotting cells drop, so a blood count is used to check the clotting cells explained in the platelet count blood test guide, and because the liver makes clotting proteins, doctors also review the clotting measurement described in the prothrombin time test guide when bleeding is a concern.
| Test or lab marker | What it shows in yellow fever | When it is used |
|---|---|---|
| RT-PCR (molecular test) | Viral genetic material, confirming active infection | The first few days after symptoms begin |
| IgM antibody test | The immune response to a recent infection | From about the end of the first week onward |
| Liver enzymes (AST and ALT) | Liver cell injury, often markedly elevated in severe disease | To judge how badly the liver is affected |
| Bilirubin | Buildup of pigment that causes jaundice | When yellowing of the skin or eyes appears |
| Platelet count and clotting time | Falling platelets and slow clotting that raise bleeding risk | To monitor for the toxic phase |
| Kidney markers (creatinine) | Signs of kidney strain or failure | In severe illness to track organ function |
Treatment and recovery
There is no specific antiviral medicine that cures yellow fever, so treatment focuses on supporting the body while it fights the infection. For mild illness that usually means rest, plenty of fluids to prevent dehydration, and acetaminophen to bring down fever and ease aches. Symptoms in the acute phase generally settle within several days, and people who do not progress to the toxic phase tend to recover fully.
One caution matters here. Doctors advise avoiding aspirin and other nonsteroidal anti-inflammatory drugs, such as ibuprofen and naproxen, because these medicines can increase the risk of bleeding, which is already a danger in severe yellow fever. Anyone who develops jaundice, bleeding, confusion, or reduced urination needs urgent hospital care. In the toxic phase, treatment moves to intensive support that may include intravenous fluids, blood products to control bleeding, medicines to steady blood pressure, and dialysis if the kidneys shut down. Prompt hospital care improves the odds, but the toxic phase remains dangerous.
Prevention
Preventing yellow fever comes down to two things: getting vaccinated and avoiding mosquito bites. For anyone living in or traveling to an endemic area, vaccination is the cornerstone, and the same bite-prevention steps that guard against other mosquito-borne illnesses add a second layer of protection.
- Get the yellow fever vaccine at least 10 days before traveling to an area where the virus circulates, and carry your certificate.
- Apply an EPA-registered insect repellent containing DEET, picaridin, IR3535, or oil of lemon eucalyptus, following the label directions.
- Wear long-sleeved shirts and long pants, and treat clothing or gear with permethrin when spending time outdoors in affected areas.
- Stay where there is air conditioning or window and door screens, and use a bed net if sleeping in an unscreened room.
- Remove standing water from containers, gutters, and plant saucers to keep mosquitoes from breeding near where you stay.
During large outbreaks, health authorities sometimes stretch limited vaccine supplies by using a smaller fractional dose, a strategy that has helped vaccinate more people quickly when demand outpaces supply.
Complications and long-term outlook
For most people, yellow fever is a short illness followed by full recovery and lifelong immunity to the virus. The outlook is very different for the minority who progress to the toxic phase, in which the liver and kidneys can fail and severe bleeding can develop. Among people who reach this stage, a large share die within a week or two, which is why early recognition and hospital care matter so much.
Those who survive the toxic phase usually recover over several weeks, often with lingering fatigue, and generally without permanent liver or kidney damage. Rarely, the infection can inflame the brain or its surrounding membranes, a serious but uncommon complication. Because outcomes hinge so heavily on prevention, vaccination before travel remains the single best way to keep a mild case from ever becoming a severe one.
Latest scientific advances in yellow fever research
One of the most active research questions is how to make a limited vaccine supply protect more people during outbreaks. A 2025 randomized noninferiority trial published in the New England Journal of Medicine tested lower, fractional doses of the 17D vaccine in adults in Uganda and Kenya and found that reduced doses produced immune protection comparable to the standard full dose (Kimathi et al., 2025). A separate preliminary report in Vaccine examined the safety of one-fifth and one-half fractional doses in young children in Uganda and found a pattern of post-vaccination reactions broadly similar to the full dose (Casey et al., 2024). What this means for you: the standard single dose remains the recommended choice for travelers, but this work supports the emergency use of fractional dosing to reach far more people when supplies run short during an outbreak.
Researchers are also searching for a treatment to fill the gap left by the absence of any antiviral drug. A 2025 study in JCI Insight reported that a yellow fever-specific neutralizing monoclonal antibody, given either before or shortly after infection, prevented lethal disease in an animal model (Rust et al., 2025). Because there is currently no medicine that targets the virus itself, a protective antibody could one day help people who are exposed or who cannot be vaccinated. What this means for you: this is early, preclinical research rather than a therapy you can request today, but it points toward a future in which a targeted treatment might blunt a severe infection.
Taken together, this research reflects a field working on both ends of the problem at once, stretching a proven vaccine further while hunting for the first real treatment. For now, the most reliable protection remains a single dose of vaccine before travel, careful mosquito-bite prevention, and understanding how a yellow fever diagnosis is confirmed through blood testing so you know what your results mean.
Glossary of key terms
| Term | Definition |
|---|---|
| Flavivirus | A family of viruses spread mainly by mosquitoes and ticks that includes yellow fever, dengue, and Zika. |
| 17D vaccine | The weakened live-virus yellow fever vaccine that gives long-lasting protection from a single dose. |
| Toxic phase | The severe second stage of yellow fever, marked by jaundice, bleeding, and liver and kidney failure. |
| Jaundice | Yellowing of the skin and eyes caused by a buildup of bilirubin when the liver is not working well. |
| Sylvatic cycle | The jungle transmission pattern in which forest mosquitoes carry the virus between monkeys and people. |
| Aedes aegypti | The mosquito that drives urban yellow fever epidemics and also spreads dengue and Zika. |
| Yellow card | The International Certificate of Vaccination or Prophylaxis that documents yellow fever vaccination for travel. |
| Fractional dose | A smaller portion of the standard vaccine dose used to extend supply during outbreaks. |
Frequently asked questions
What are the early symptoms of yellow fever?
The first symptoms usually appear 3 to 6 days after an infected mosquito bite and come on suddenly. They include fever and chills, a severe headache, back and muscle pain, nausea, and loss of appetite. In most people this acute phase eases within three to four days and recovery follows. The warning signs that the illness is becoming serious are jaundice, dark urine, and any bleeding, which call for urgent medical care.
Is there a cure or specific medicine for yellow fever?
No specific antiviral medicine cures yellow fever. Treatment is supportive, meaning it focuses on rest, fluids, and acetaminophen for fever while the immune system clears the virus, with intensive hospital care for severe cases. Aspirin and other nonsteroidal anti-inflammatory drugs are avoided because they can raise the risk of bleeding. Researchers are testing antibody treatments in the laboratory, but none is available yet.
How long does yellow fever vaccine protection last?
For most people, a single dose of the yellow fever vaccine provides protection for life. The World Health Organization no longer recommends a routine booster, and the international vaccination certificate has been valid for the lifetime of the vaccinated person since 2016. A clinician may still consider an extra dose for certain travelers, such as some people who were vaccinated during pregnancy or while immunocompromised.
Can a blood test confirm yellow fever?
Yes. In the first few days of illness, an RT-PCR test can detect the virus’s genetic material in the blood, and later an antibody test can find the immune response to a recent infection. Because related viruses can cross-react, an unclear antibody result may need a confirmatory neutralization test. Additional blood work, including liver enzymes, bilirubin, and platelet counts, helps doctors judge how severe the infection is.
Is yellow fever contagious from person to person?
Yellow fever does not spread through everyday contact such as coughing, touching, or sharing food. It passes only through the bite of an infected mosquito. However, a person with the virus in their blood can infect a mosquito that later bites someone else, which is how urban outbreaks spread. Preventing bites and vaccinating the community both help break that chain.
Is the yellow fever vaccine required for travel?
Many countries require proof of yellow fever vaccination to enter, especially if you are arriving from or have traveled through a country where the virus circulates. The proof is an International Certificate of Vaccination or Prophylaxis, the yellow card, and it takes effect 10 days after vaccination. Check the current entry rules for your destination well before you travel, and get vaccinated at an authorized center.
Sources
- Centers for Disease Control and Prevention — Symptoms, Diagnosis, and Treatment of Yellow Fever — CDC Yellow Fever, 2024 — cdc.gov
- Centers for Disease Control and Prevention — Yellow Fever Vaccine — CDC Yellow Fever, 2024 — cdc.gov
- World Health Organization — Yellow Fever Fact Sheet — WHO Newsroom, 2024 — who.int
- Cleveland Clinic — Yellow Fever: Symptoms, Causes and Treatments — Cleveland Clinic Health Library, 2023 — my.clevelandclinic.org
- Kimathi D, Juan-Giner A, Bob NS, et al. — Low-Dose Yellow Fever Vaccine in Adults in Africa — New England Journal of Medicine, 2025 — doi.org/10.1056/NEJMoa2407293
- Casey RM, Harris JB, Ahuka-Mundeke S, et al. — Adverse events following immunization with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda — Vaccine, 2024 — doi.org/10.1016/j.vaccine.2024.126197
- Rust BJ, Marceau AH, Fuller JR, et al. — Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infection — JCI Insight, 2025 — doi.org/10.1172/jci.insight.191665
Further reading
- Compare another fever that travelers can pick up abroad by reading this guide to typhoid fever symptoms, causes, and treatment.
- See another infection that causes jaundice and liver inflammation in this guide to hepatitis A symptoms, causes, and treatment.
- Understand the kidney marker that can rise in severe yellow fever by reading this guide to your creatinine blood test results.
- Learn how doctors read platelets and other cells together in this guide to the complete blood count.
- Build a fuller picture of your own numbers with this guide to reading reference ranges, flags, and trends in a lab report.
Understand your lab results with BloodSense
A yellow fever diagnosis rests on laboratory testing, from an RT-PCR test that finds the virus early to the liver enzymes, bilirubin, and platelet counts that show how the infection is affecting your body. Those same blood tests can be hard to interpret on your own, especially when a report is full of reference ranges, flags, and unfamiliar markers. BloodSense translates a full lab report into plain language, showing where each value sits relative to its normal range and helping you understand what your results actually mean for your health.
